Immuno-Oncology Drugs Global Market Opportunities And Strategies To 2031

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	304 Pages	The Business Research Company	July, 2022	BRC17291439

Best Price Guarantee
Price	from $5,000
Length	304 Pages
Publisher	The Business Research Company
Published Date	July, 2022
SKU	BRC17291439

Immuno-Oncology Drugs Global Market Opportunities And Strategies To 2031

Immuno-Oncology Drugs Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global immuno-oncology drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest growing market for immuno-oncology drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immuno-oncology drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider immuno-oncology drugs market; and compares it with other markets.

The report covers the following chapters

Executive Summary – The executive summary section of the report gives a brief overview and summary of the report

Report Structure – This section gives the structure of the report and the information covered in the various sections.

Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, segmentation by therapeutic application, and segmentation by end users.

Market Characteristics – The market characteristics section of the report defines and explains the immuno-oncology drugs market. This chapter also defines and describes goods and related services covered in the report.

Trends And Strategies – This chapter describes the major trends shaping the global immuno-oncology drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of COVID-19 – This section describes the impact of COVID-19 on the immuno-oncology drugs market.

Global Market Size And Growth – This section contains the global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis – This section contains the historic (2016-2021) and forecast (2021-2026, and 2026-2031) market values and growth and market share comparison by region.

Segmentation – This section contains the market values (2016-2031) and analysis for different segments.

Regional Market Size and Growth – This section contains the region’s market size (2021), historic (2016-2021) and forecast (2021-2026, and 2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape – This section covers details on the competitive landscape of the global immuno-oncology drugs market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions – This section gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusion and Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for immuno-oncology drugs providers in terms of product offerings, geographic expansion, marketing strategies and target groups.

Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered: 1) By Type: Immune Checkpoint Inhibitors; Immune System Modulators; Other Monoclonal Antibodies; Cancer Vaccines; Others

2) By Therapeutic Application: Melanoma; Lung Cancer; Blood Cancer; Renal Cell Carcinoma; Bladder Cancer; Other Therapeutic Application

3) By End-Users: Hospitals; Clinics; Ambulatory Surgical Centers; Others

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co.; Bristol-Myers Squibb Company; Amgen Inc; Johnson & Johnson

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; immuno-oncology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Immuno-Oncology Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction: 6.1. Segmentation By Geography; 6.2. Segmentation By Type; 6.3. Segmentation By Therapeutic Application; 6.4. Segmentation By End Users
7. Immuno-Oncology Drugs Market Characteristics: 7.1. Market Definition; 7.2. Market Segmentation By Type; 7.2.1. Immune Checkpoint Inhibitors; 7.2.2. Immune System Modulators; 7.2.3. Other Monoclonal Antibodies; 7.2.4. Cancer Vaccines; 7.2.5. Others; 7.3. Market Segmentation By Therapeutic Application; 7.3.1. Melanoma; 7.3.2. Lung Cancer; 7.3.3. Blood Cancer; 7.3.4. Renal Cell Carcinoma; 7.3.5. Prostate Cancer; 7.3.6. Bladder Cancer; 7.3.7. Others; 7.4. Market Segmentation By End User; 7.4.1. Hospitals; 7.4.2. Clinics; 7.4.3. Ambulatory Surgical Centers; 7.4.4. Cancer Research Institutes
8. Immuno-Oncology Drugs Market Trends and Strategies: 8.1. Increasing Usage of Microneedle Pills; 8.2. Development Of Personalized Cancer Vaccines; 8.3. Increase In Acquisition Activity Among Immuno-Oncology Drug Market Players; 8.4. Development And Increasing Demand For Next-Generation Biologics; 8.5. Investment In Artificial Intelligence For Oncology Drugs; 8.6. Use Of 3D Printing To Test New Oncology Drugs; 8.7. Immuno-Oncology Combination Therapies; 8.8. CAR-T Cell Therapy
9. COVID Impact On The Immuno-Oncology Drugs Market: 9.1. COVID-19 Pandemic Effects On Cancer Patients and Survivors; 9.2. Clinical Trial Delays; 9.3. Low Usage Of Drugs; 9.4. Supply Chain Issues; 9.5. Future Outlook
10. Global Immuno-Oncology Drugs Market Size And Growth: 10.1. Market Size; 10.2. Historic Market Growth, 2016 – 2021, Value ($ Million); 10.2.1. Drivers Of The Market 2016-2021; 10.2.2. Restraints On The Market 2016 – 2021; 10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 10.3.1. Drivers Of The Market 2021 – 2026; 10.3.2. Restraints On The Market 2021 – 2026
11. Global Immuno-Oncology Drugs Market Segmentation: 11.1. Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.2. Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.3. Global Immuno-Oncology Drugs Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12. Immuno-Oncology Drugs Market, Regional And Country Analysis: 12.1. Global Immuno-Oncology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.2. Global Immuno-Oncology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13. Asia-Pacific Immuno-Oncology Drugs Market: 13.1. Asia-Pacific Immuno-Oncology Drugs Market Overview; 13.1.1. Region Information; 13.1.2. Market Information; 13.1.3. Background Information; 13.1.4. Government Initiatives; 13.1.5. Regulations; 13.1.6. Regulatory Bodies; 13.1.7. Major Associations; 13.1.8. Taxes Levied; 13.1.9. Corporate Tax Structure; 13.1.10. Investments; 13.1.11. Major Companies; 13.2. Asia-Pacific Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.3. Asia-Pacific Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.4. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.5. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.6. Asia-Pacific Immuno-Oncology Drugs Market: Country Analysis; 13.7. China Immuno-Oncology Drugs Market; 13.8. China Immuno-Oncology Drugs Market Overview; 13.8.1. Region Information; 13.8.2. Market Information; 13.8.3. Background Information; 13.8.4. Government Initiatives; 13.8.5. Regulations; 13.8.6. Regulatory Bodies; 13.8.7. Major Associations; 13.8.8. Taxes Levied; 13.8.9. Corporate Tax Structure; 13.8.10. Investments; 13.8.11. Major Companies; 13.9. China Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.10. China Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.11. China Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.12. China Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.13. India Immuno-Oncology Drugs Market; 13.14. India Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.15. India Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.16. India Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.17. India Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.18. Japan Immuno-Oncology Drugs Market; 13.19. Japan Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.20. Japan Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.21. Japan Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.22. Japan Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.23. Australia Immuno-Oncology Drugs Market; 13.24. Australia Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.25. Australia Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.26. Australia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.27. Australia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.28. Indonesia Immuno-Oncology Drugs Market; 13.29. Indonesia Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.30. Indonesia Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.31. Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.32. Indonesia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.33. South Korea Immuno-Oncology Drugs Market; 13.34. South Korea Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.35. South Korea Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.36. South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.37. South Korea Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14. Western Europe Immuno-Oncology Drugs Market: 14.1. Western Europe Immuno-Oncology Drugs Market Overview; 14.1.1. Region Information; 14.1.2. Market Information; 14.1.3. Background Information; 14.1.4. Government Initiatives; 14.1.5. Regulations; 14.1.6. Regulatory Bodies; 14.1.7. Major Associations; 14.1.8. Taxes Levied; 14.1.9. Corporate Tax Structure; 14.1.10. Investments; 14.1.11. Major Companies; 14.2. Western Europe Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 14.3. Western Europe Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 14.4. Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.5. Western Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.6. Western Europe Immuno-Oncology Drugs Market: Country Analysis; 14.7. UK Immuno-Oncology Drugs Market; 14.8. UK Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 14.9. UK Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 14.10. UK Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.11. UK Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.12. Germany Immuno-Oncology Drugs Market; 14.13. Germany Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 14.14. Germany Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 14.15. Germany Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.16. Germany Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.17. France Immuno-Oncology Drugs Market; 14.18. France Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 14.19. France Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 14.20. France Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.21. France Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15. Eastern Europe Immuno-Oncology Drugs Market: 15.1. Eastern Europe Immuno-Oncology Drugs Market Overview; 15.1.1. Region Information; 15.1.2. Market Information; 15.1.3. Background Information; 15.1.4. Government Initiatives; 15.1.5. Regulations; 15.1.6. Regulatory Bodies; 15.1.7. Major Associations; 15.1.8. Taxes Levied; 15.1.9. Corporate Tax Structure; 15.1.10. Investments; 15.1.11. Major Companies; 15.2. Eastern Europe Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 15.3. Eastern Europe Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 15.4. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 15.5. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 15.6. Eastern Europe Immuno-Oncology Drugs Market: Country Analysis; 15.7. Russia Immuno-Oncology Drugs Market; 15.8. Russia Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 15.9. Russia Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 15.10. Russia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 15.11. Russia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16. North America Immuno-Oncology Drugs Market: 16.1. North America Immuno-Oncology Drugs Market Overview; 16.1.1. Region Information; 16.1.2. Market Information; 16.1.3. Background Information; 16.1.4. Government Initiatives; 16.1.5. Regulations; 16.1.6. Regulatory Bodies; 16.1.7. Major Associations; 16.1.8. Taxes Levied; 16.1.9. Corporate Tax Structure; 16.1.10. Investments; 16.1.11. Major Companies; 16.2. North America Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 16.3. North America Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 16.4. North America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 16.5. North America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 16.6. North America Immuno-Oncology Drugs Market: Country Analysis; 16.7. USA Immuno-Oncology Drugs Market; 16.8. USA Immuno-Oncology Drugs Market Overview; 16.8.1. Region Information; 16.8.2. Market Information; 16.8.3. Background Information; 16.8.4. Government Initiatives; 16.8.5. Regulations; 16.8.6. Regulatory Bodies; 16.8.7. Major Associations; 16.8.8. Taxes Levied; 16.8.9. Corporate Tax Structure; 16.8.10. Investments; 16.8.11. Major Companies; 16.9. USA Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 16.10. USA Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 16.11. USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 16.12. USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17. South America Immuno-Oncology Drugs Market: 17.1. South America Immuno-Oncology Drugs Market Overview; 17.1.1. Region Information; 17.1.2. Market Information; 17.1.3. Background Information; 17.1.4. Government Initiatives; 17.1.5. Regulations; 17.1.6. Regulatory Bodies; 17.1.7. Major Associations; 17.1.8. Taxes Levied; 17.1.9. Corporate Tax Structure; 17.1.10. Investments; 17.1.11. Major Companies; 17.2. South America Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 17.3. South America Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 17.4. South America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 17.5. South America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 17.6. South America Immuno-Oncology Drugs Market: Country Analysis; 17.7. Brazil Immuno-Oncology Drugs Market; 17.8. Brazil Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 17.9. Brazil Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 17.10. Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 17.11. Brazil Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
18. Middle East Immuno-Oncology Drugs Market: 18.1. Middle East Immuno-Oncology Drugs Market Overview; 18.1.1. Region Information; 18.1.2. Market Information; 18.1.3. Background Information; 18.1.4. Government Initiatives; 18.1.5. Regulations; 18.1.6. Regulatory Bodies; 18.1.7. Major Associations; 18.1.8. Taxes Levied; 18.1.9. Corporate Tax Structure; 18.1.10. Investments; 18.1.11. Major Companies; 18.2. Middle East Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 18.3. Middle East Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 18.4. Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 18.5. Middle East Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
19. Africa Immuno-Oncology Drugs Market: 19.1. Africa Immuno-Oncology Drugs Market Overview; 19.1.1. Region Information; 19.1.2. Market Information; 19.1.3. Background Information; 19.1.4. Government Initiatives; 19.1.5. Regulations; 19.1.6. Regulatory Bodies; 19.1.7. Major Associations; 19.1.8. Taxes Levied; 19.1.9. Corporate Tax Structure; 19.1.10. Investments; 19.1.11. Major Companies; 19.2. Africa Immuno-Oncology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 19.3. Africa Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 19.4. Africa Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 19.5. Africa Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
20. Global Immuno-Oncology Drugs Market Competitive Landscape: 20.1. Company Profiles; 20.2. F. Hoffmann-La Roche Ltd. (Roche); 20.2.1. Company Overview; 20.2.2. Products And Services; 20.2.3. Business Strategy; 20.2.4. Financial Overview; 20.3. Merck & Co.; 20.3.1. Company Overview; 20.3.2. Products And Services; 20.3.3. Business Strategy; 20.3.4. Financial Overview; 20.4. Bristol-Myers Squibb Company; 20.4.1. Company Overview; 20.4.2. Products And Services; 20.4.3. Business Strategy; 20.4.4. Financial Overview; 20.5. Amgen Inc; 20.5.1. Company Overview; 20.5.2. Products And Services; 20.5.3. Business Strategy; 20.5.4. Financial Overview; 20.6. Johnson & Johnson (J&J); 20.6.1. Company Overview; 20.6.2. Products And Services; 20.6.3. Business Strategy; 20.6.4. Financial Overview
21. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market: 21.1. Sanofi Acquired Amunix Pharmaceuticals Inc.; 21.2. Takeda Yet To Acquire Adaptate Biotherapeutics; 21.3. Takeda Acquired GammaDelta Therapeutics; 21.4. Pfizer Acquired Trillium Therapeutics; 21.5. Amgen Acquired Teneobio Inc.; 21.6. True North Acquired Stake In Biocon Biologics Ltd.; 21.7. PAG Acquired Stake In Hisun BioRay; 21.8. Eli Lilly And Company Acquired Loxo Oncology, Inc.; 21.9. Fuji Pharma Co., Ltd. Acquired Stake In Alvotech; 21.10. Bristol-Myers Squibb Acquired Celgene Corporation; 21.11. Kashiv Pharma, LLC Acquired Adello Biologics; 21.12. Takeda Pharmaceutical Company Limited Acquired Shire Plc; 21.13. GlaxoSmithKline Plc Acquired Tesaro Inc.
22. Immuno-Oncology Drugs Market Opportunities And Strategies: 22.1. Global Immuno-Oncology Drugs Market In 2026 – Countries Offering Most New Opportunities; 22.2. Global Immuno-Oncology Drugs Market In 2026 – Segments Offering Most New Opportunities; 22.3. Global Immuno-Oncology Drugs Market In 2026 – Growth Strategies; 22.3.1. Market Trend Based Strategies; 22.3.2. Competitor Strategies
23. Immuno-Oncology Drugs Market, Conclusions And Recommendations: 23.1. Conclusions; 23.2. Recommendations; 23.2.1. Product; 23.2.2. Place; 23.2.3. Price; 23.2.4. Promotion; 23.2.5. People
24. Appendix: 24.1. Market Data Sources; 24.2. Research Methodology; 24.3. Currencies; 24.4. Research Inquiries; 24.5. The Business Research Company; 24.6. Copyright and Disclaimer; 24.7.